Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP584754.RAlDuixpOcRV7wbCrkmsqV8HcBV0Kg2OoQvXTEx_rU9mE130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584754.RAlDuixpOcRV7wbCrkmsqV8HcBV0Kg2OoQvXTEx_rU9mE130_provenance.
• NP634909.RA4fGTgeqTCqQ22qU0KE6w8ilctSZPbi7pHE4-KdSr4bU130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634909.RA4fGTgeqTCqQ22qU0KE6w8ilctSZPbi7pHE4-KdSr4bU130_provenance.
• NP641650.RAMNCjoY3s1cje59mRMzy7G7adIQUtjZYXmUuv-A7mQng130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641650.RAMNCjoY3s1cje59mRMzy7G7adIQUtjZYXmUuv-A7mQng130_provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP693877.RADNgFp90itjo59iauzmgGYl-xfCHM7XhP12vg3VOIOOk130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693877.RADNgFp90itjo59iauzmgGYl-xfCHM7XhP12vg3VOIOOk130_provenance.
• NP644753.RADVmY1js-rA7PBvUQz8zm5vOCfbEpJwcOVeS5DHSQLcw130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644753.RADVmY1js-rA7PBvUQz8zm5vOCfbEpJwcOVeS5DHSQLcw130_provenance.
• NP693878.RAaCp89ZFwIqOfaKKwCbcdtJrDY7gpKK4Q7gnYT-FaB_k130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693878.RAaCp89ZFwIqOfaKKwCbcdtJrDY7gpKK4Q7gnYT-FaB_k130_provenance.
• NP693880.RATrVI0XSQxywg03e5iOho2ds0EenvlY_76LFSkMkdq4o130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693880.RATrVI0XSQxywg03e5iOho2ds0EenvlY_76LFSkMkdq4o130_provenance.
• NP693882.RAWqYzyiejl8ZPudvj9zJ-dbw9iYMpyFmv2cZB4fTrFgc130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693882.RAWqYzyiejl8ZPudvj9zJ-dbw9iYMpyFmv2cZB4fTrFgc130_provenance.
• NP693884.RAYbtV33Hu63RD6-wOeSnmLn9IeyBYCRIRZWdUddO0Hu4130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693884.RAYbtV33Hu63RD6-wOeSnmLn9IeyBYCRIRZWdUddO0Hu4130_provenance.
• NP233065.RAiZTPh9drGsFF06KKJ5vQyVUPRn1d8xXokkEep8QJ6f8130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233065.RAiZTPh9drGsFF06KKJ5vQyVUPRn1d8xXokkEep8QJ6f8130_provenance.
• NP644990.RAveBGiE5k3Gy27C11XgtR_2RskpMSH2umbIVFKi-Xmh0130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644990.RAveBGiE5k3Gy27C11XgtR_2RskpMSH2umbIVFKi-Xmh0130_provenance.
• NP693871.RAlOQUUei-6ZIFPR0N_nfefIJfmuztBPD-aLk4v56iALc130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693871.RAlOQUUei-6ZIFPR0N_nfefIJfmuztBPD-aLk4v56iALc130_provenance.
• NP693872.RAqXd63-bpIpB6c64ldLQbBmafIbeQelZ00hhN0bsSTtk130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693872.RAqXd63-bpIpB6c64ldLQbBmafIbeQelZ00hhN0bsSTtk130_provenance.
• NP693875.RAmyfTHEBxMJbs-dZchqap5nt488yH_ITyzbBr-WGHxjc130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693875.RAmyfTHEBxMJbs-dZchqap5nt488yH_ITyzbBr-WGHxjc130_provenance.
• NP693876.RAkRUli51swCuqufVq5rpuGhXkJvTn93H9LvrX69n_UvI130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693876.RAkRUli51swCuqufVq5rpuGhXkJvTn93H9LvrX69n_UvI130_provenance.
• NP232916.RA_oDB23P9uKPDQyKp8C4TXxTAW8QOSKfc5OqulMiPe8s130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232916.RA_oDB23P9uKPDQyKp8C4TXxTAW8QOSKfc5OqulMiPe8s130_provenance.
• NP232917.RAKfctYshI1NZbBnv_OlrPWqpFz5GcF27K7CI4Q-9yN_c130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232917.RAKfctYshI1NZbBnv_OlrPWqpFz5GcF27K7CI4Q-9yN_c130_provenance.
• NP644745.RA_6fsuI3HkMhe8orUo028ula2P3_KqOoZzDQRmxPl4OE130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644745.RA_6fsuI3HkMhe8orUo028ula2P3_KqOoZzDQRmxPl4OE130_provenance.
• NP801454.RAEqJqfgW-RYHH_fNegKfYwXKTA1zQa-3BHoATOs1UgpA130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801454.RAEqJqfgW-RYHH_fNegKfYwXKTA1zQa-3BHoATOs1UgpA130_provenance.
• NP693879.RAM75eRNdwl9QDyt1gu9dwMSyGl6NgFYbH-NlyGeptnC4130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693879.RAM75eRNdwl9QDyt1gu9dwMSyGl6NgFYbH-NlyGeptnC4130_provenance.
• NP684879.RA-o21iUr6EH6pWinvwb13vn4k4Gd7fMEOH0RS9kdximM130_assertion description "[Enhanced levels of MCP1 resulting from reduced IRS2 expression and accompanying defects in AKT2 and Ras/ERK1/2 signaling pathways may contribute to accelerated atherosclerosis in MetS states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684879.RA-o21iUr6EH6pWinvwb13vn4k4Gd7fMEOH0RS9kdximM130_provenance.